文献速递关节外科运动医学

解剖型与反式肩关节置换术治疗肩袖完整的盂肱骨关节炎的价值分析

Value Analysis of Anatomic and Reverse Shoulder Arthroplasty for Glenohumeral Osteoarthritis with an Intact Rotator Cuff.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

本研究采用回顾性匹配队列设计,比较解剖型全肩关节置换术(TSA)与反式肩关节置换术(RSA)治疗肩袖完整的盂肱骨关节炎患者(至少2年随访)的结局与价值。结果显示两组在住院费用、收费、报销、以最小临床重要差异(MCID)单位衡量的结局改善及患者满意度上均无差异;RSA假体成本显著更高,但手术室、麻醉和骨水泥成本更低。结论认为TSA与RSA的结局和价值相似。

要点

  • TSA与RSA在肩袖完整的盂肱骨关节炎中结局改善和患者满意度无差异。
  • RSA假体成本显著高于TSA,但手术室、麻醉和骨水泥成本更低。
  • TSA组影像学松动率3.2%、翻修率2.4%,RSA组无松动或翻修。

核心结论

  • TSA和RSA治疗肩袖完整的盂肱骨关节炎时表现出相似的结局和价值。

研究设计与样本

  • 回顾性匹配队列研究,纳入因骨关节炎且肩袖完整接受初次肩关节置换术且至少随访2年的患者。

主要发现

  • 两组总住院费用、收费和报销以及以MCID单位衡量的结局改善和患者满意度均无差异。
  • RSA假体成本显著高于TSA,但手术室、麻醉和骨水泥成本更低。
  • TSA组影像学严重盂假体松动率为3.2%,翻修率为2.4%;RSA组无松动或翻修。
  • 即使纳入早期TSA翻修的结局和成本,两组间价值分析指标仍无差异。

关键数值与推荐

  • 结局指标包括SST、ASES问卷、疼痛VAS、SANE和总体满意度。
  • 价值差异通过平均成本效果比(ACER)、增量成本效果比(ICER)和手术价值指数(PVI)计算。

临床怎么用

  • 对于肩袖完整的盂肱骨关节炎,TSA和RSA均可作为治疗选择,两者结局和价值相似。
  • 需结合假体成本与手术室、麻醉等成本差异综合评估两种术式的经济性。

局限性

  • 本研究为回顾性设计,证据等级为治疗性III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While anatomic total shoulder arthroplasty (TSA) has historically been considered the ideal treatment for end-stage glenohumeral osteoarthritis, reverse shoulder arthroplasty (RSA) has recently gained popularity. With substantial differences in implant design and cost between TSA and RSA, further investigation of outcomes and value is needed to support recent trends. The purpose of this study was to use the average and incremental cost-effectiveness ratio (ACER and ICER) and the procedure value index (PVI) to examine differences in outcomes and value between TSA and RSA for treatment of glenohumeral osteoarthritis with an intact rotator cuff. METHODS: We performed a retrospective matched-cohort study of patients treated with primary shoulder arthroplasty for osteoarthritis with an intact rotator cuff who had a minimum 2-year follow-up. Outcome measures analyzed included the Simple Shoulder Test (SST), American Shoulder and Elbow Surgeons (ASES) questionnaire, visual analog scale (VAS) for pain, Single Assessment Numeric Evaluation (SANE), and overall satisfaction. Patients treated with TSA were matched 4:1 to those treated with RSA based on sex, age, and preoperative SST score. Value differences between TSA and RSA were calculated. Radiographs were analyzed for preoperative glenoid classification and postoperative radiolucent lines and gross loosening. RESULTS: Two hundred and fifty-two TSA-treated patients were matched to 63 RSA-treated patients with no significant differences in sex, age, or preoperative SST score. Total hospitalization costs, charges, and reimbursements along with outcome improvements in units of minimal clinically important differences (MCIDs) and patient satisfaction did not differ between the groups. For RSA, the implant cost was significantly higher than that for TSA, but the operating room, anesthesia, and cement costs were lower. The TSA group had a 3.2% rate of gross glenoid loosening and a 2.4% revision rate. There was no loosening or revision in the RSA group. None of the value analytics differed between groups even after inclusion of the outcomes and costs of early TSA revisions. CONCLUSIONS: TSA and RSA demonstrated similar outcomes and value when used to manage glenohumeral osteoarthritis with an intact rotator cuff. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Polisetty TS, Colley R, Levy JC, et al. Value Analysis of Anatomic and Reverse Shoulder Arthroplasty for Glenohumeral Osteoarthritis with an Intact Rotator Cuff. J Bone Joint Surg Am. 2021. PMID: 33983149. doi:10.2106/JBJS.19.01398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。